Talon Therapeutics to Host a Conference Call to Report Third Quarter 2012 Financial Results and Business Update on November 14, 2012
12 nov. 2012 09h00 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 12, 2012 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc. (OTCBB:TLON) will host a conference call on Wednesday, November 14, 2012 at 9:00AM PST, to discuss third quarter...
Talon Therapeutics, Inc. Reports Second Quarter 2012 Financial Results
13 août 2012 09h00 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 13, 2012 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc., (OTCBB:TLON), today reported financial results for the three and six months ended June 30, 2012.
"The FDA's...
Talon Therapeutics' Marqibo(R) (vinCRIStine sulfate LIPOSOME injection) Granted Accelerated Approval by FDA
09 août 2012 12h27 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 9, 2012 (GLOBE NEWSWIRE) -- Talon Therapeutics today announced Marqibo® (vinCRIStine sulfate LIPOSOME injection) received accelerated approval from the U.S. Food...
Talon Therapeutics to Host a Conference Call to Report Second Quarter 2012 Financial Results and Business Update on August 13, 2012
06 août 2012 09h00 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 6, 2012 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc. (OTCBB:TLON) will host a conference call on Monday, August 13, 2012 at 9:00AM PDT, to discuss second quarter 2012...
Talon Therapeutics Announces Enrollment and Dosing of the First Patient in the Phase 3 Confirmatory Study of Marqibo(R) in Adult Patients With Newly Diagnosed Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia (HALLMARQ Study)
01 juin 2012 08h00 HE
|
Talon Therapeutics, Inc.
SAN MATEO, Calif., June 1, 2012 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc., (OTCBB:TLON) announced enrollment and dosing of the first patient in the Phase 3 confirmatory study of Marqibo®...
Talon Therapeutics Appoints Head of Commercial Operations and Planning
22 mai 2012 08h00 HE
|
Talon Therapeutics, Inc.
SAN MATEO, Calif., May 22, 2012 (GLOBE NEWSWIRE) -- Talon Therapeutics Inc. (OTCBB:TLON) today announced the appointment of Thomas DeZao to head the commercial operations and planning function. Mr....
Talon Therapeutics, Inc. Reports First Quarter 2012 Financial Results
15 mai 2012 08h00 HE
|
Talon Therapeutics, Inc.
SAN MATEO, Calif., May 15, 2012 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc., (OTCBB:TLON), today reported financial results for the three months ended March 31, 2012.
"In the first quarter, the...
Talon Therapeutics to Host a Conference Call to Report First Quarter 2012 Financial Results and Business Update on May 15, 2012
11 mai 2012 09h00 HE
|
Talon Therapeutics, Inc.
SAN MATEO, Calif., May 11, 2012 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc. (OTCBB:TLON) will host a conference call on Tuesday, May 15, 2012 at 9:00AM PDT, to discuss first quarter 2012 financial...
Talon Therapeutics Receives Notification of Three Month PDUFA Date Extension for Marqibo(R)
07 mai 2012 09h00 HE
|
Talon Therapeutics, Inc.
SAN MATEO, Calif., May 7, 2012 (GLOBE NEWSWIRE) -- Talon Therapeutics Inc., (OTCBB:TLON), today announced that it has been informed by the U.S. Food and Drug Administration (FDA) that its New Drug...
Talon Therapeutics Appoints Howard Pien to Board of Directors
24 avr. 2012 13h11 HE
|
Talon Therapeutics, Inc.
SAN MATEO, Calif., April 24, 2012 (GLOBE NEWSWIRE) -- Talon Therapeutics (OTCBB:TLON), a biopharmaceutical company focused on expert and efficient clinical development of product candidates targeting...